Minimally invasive endoluminal procedures for gastro-esophageal reflux disease (GERD)

Series
Procedures on upper gastrointestinal tract
Status
Ongoing
Date
Number of report
021

Ask the expert

(we accept only company emails)

Report presents summary of reimbursement situation for procedures to treat gastro-esophageal reflux disease (GERD) in European countries.           

Four minimally invasive procedures are considered in the report:

  • Radiofrequency ablation
  • Endoscopic plication and suturing
  • Injection of bulking agents

Report includes essential information about reimbursement and national funding, including:

  • Brief overview of reimbursement system for medical devices
  • Procedure coding for technology
  • Diagnosis coding
  • Payment mechanism for technology
  • Reimbursement tariffs for technology
  • Restrictions in indications or scenarios for use of technology
  • Policy considerations by payers and policy-makers about technology

Reimbursement information is provided for the following geographies:

  • Austria
  • Belgium
  • Denmark
  • England (UK)
  • France
  • Germany
  • Italy
  • Netherlands
  • Norway
  • Sweden
  • Switzerland

Manufacturers of devices for endoluminal treatment of gastro-esophageal reflux disease (GERD) include:

Radiofrequency ablation

  • Mederi Therapeutics (Stretta System)
  • Medtronic (Barrx radiofrequency ablation system)

Endoscopic plication and suturing

  • Apollo Endosurgery (OverStitch Endoscopic Suturing System)
  • C.R.Bard (EndoCinch device)
  • Endogastric Solutions (EsophyX System)
  • Medigus (SRS Endoscopic Stapling System)
  • Medtronic (Gatekeeper Reflux Repair System)

Injection of bulking agents

  • Carbon Medical Technologies (Durasphere GR)

Endoscopic augmentation of the lower oesophageal sphincter using hydrogel implants

  • Boston Scientific (Enteryx Device)
  • Medtronic (Gatekeeper Reflux Repair System)

    Table of content is not available at the moment.

    04

    Jun 2018

    Report includes analysis for the following procedures: radiofrequency ablation, endoscopic plication and suturing, injection of bulking agents and endoscopic augmentation of the lower esophageal sphincter using hydrogel implants. The analysis covers procedure coding, payment mechanism, reimbursement tariffs and policy restrictions in 11 EU countries including Austria, Belgium, Denmark, England, France, Germany, Italy, the Netherlands, Norway, Sweden and Switzerland.

    Read more

    11

    Jan 2018

    The Clinical Coding and Schedule Development Group develops and maintains procedural and diagnostics nomenclature for private payers in England. In November new codes for reconstruction of breast, open adnexectomy, transoral laser microsurgery and surgical correction of hallux valgus were added to the CCSD Schedule.

    Read more

    22

    Jun 2017

    The Clinical Coding and Schedule Development Group develops and maintains procedural and diagnostics nomenclature for private payers in England. Several codes were added to both procedural and diagnostic Schedules, including procedures on spine and endoscopy procedure.

    Read more

    06

    Jun 2017

    HAS published updated program that defines priority areas of work for 2017, including evidence review as part of developing new procedure codes for robotic surgery, endoscopic procedures, and technology assessments of remote monitoring, dialysis, coronary stents and others.

    Read more

    05

    Jun 2017

    In second two weeks of May, National Institute for Health and Care Excellence has published two Medtech Innovation Briefings (collagen paste for anal fistulae and portable pulse‑echo ultrasound device to assist diagnosis of osteoporosis) one Interventional Procedure Guidance for endoscopic full thickness removal of non-lifting colonic polyps.

    Read more

    16

    May 2017

    Changes will be made in nine chapters of Nomenclature. In relation to medical technologies and in-vitro diagnostics, the most important changes include changes in conditions for two ophthalmology and endoscopy codes, new conditions for reimbursement of photodynamic therapy in dermatology, introduction of two new codes for IVDs, and creating of requirements for reimbursement of number of IVD tests in pregnancy.

    Read more

    28

    Apr 2017

    Three mini-HTAs were published since beginning of 2017: procalcitonin for diagnostic of bacterial infections, Per Oral Endoscopic Myotomy (POEM) for achalasia, and use of the Prosigna test (PAM50 ROR) for decisions on adjuvant treatment in breast cancer. These assessments can support introduction of methods at local hospital level in Norway.

    Read more
    (we accept only company emails)